IGF-IR is a receptor that, when activated by insulin-like growth factors (IGFs), triggers downstream signaling pathways that promote cell growth, survival, and metabolism; these factors have been studied in COVID-19 in association with clinical parameters (60–63). Here, IGF1R is linked to COVID-19.